Prof. Dr. Anna Naumova is a Research Associate Professor of Radiology at the University of
Washington. She works closely with the Vascular Imaging Laboratory and the
Cardiothoracic and Abdominal Advanced Imaging Lab. Dr. Naumova graduated from
the Tomsk State University (Russia) with an MS in biology and applied
informatics. She obtained her PhD degree from the Institute of Cardiology
(Russia) and Doctor Habilitatus (Habil.D.) degree from the Lomonosov Moscow
State University, Russia. Her postgraduate training was conducted at Johns
Hopkins University (USA) to study cardiac energy metabolism and contractile
function using MRI and spatially localized 31P MR spectroscopy in mouse models
of human diseases. During her postdoctoral fellowship at the Vascular Imaging
Laboratory (University of Washington, USA), she investigated the pathophysiological
mechanisms of atherosclerosis and the efficacy of human stem cell-derived
cardiomyocyte transplantation into the infarcted heart on animal models. Dr.
Naumova has over 15 years of experience in the development of acquisition
sequences and analysis software tools for translational magnetic resonance
imaging (MRI) applications. The ultimate goal of her research is to bring new
quantitative imaging technologies to address the unmet needs of regenerative
medicine, heart and brain tissue characterization, and the non-invasive imaging of
heart failure treatment with transplanted cells.
Prof. Dr. Vasily Yarnykh is a Research Professor of Radiology at the University of Washington
and an expert in magnetic resonance physics and quantitative MRI methods. He
obtained his M.S. and Ph.D. in Chemistry from the Lomonosov Moscow State
University, Moscow, Russia, in 1988 and 1992, respectively. He conducted his postgraduate
training at the Lomonosov Moscow State University in 1992–1993 and at the University
of Washington in 2000–2003. Dr. Yarnykh is an inventor of a number of widely
used MRI technologies, including several efficient blood signal suppression
techniques for cardiovascular imaging, the actual flip-angle imaging method for
fast and robust B1 field mapping, and the fast macromolecular proton fraction
(MPF) mapping method for quantitative myelin imaging. Since receiving a
High-Impact Neuroscience Research Resource Grant from the NIH in 2018, his work has
mainly focused on the development and widespread distribution of MPF
mapping technology as a uniform approach to quantify myelin in the central
nervous system for clinical and pre-clinical research. Dr. Yarnykh closely
collaborates with I-LABS, providing continuous support of MRI acquisition
protocols and image processing algorithms.
